Gene · 5139
Papers1,182
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,182
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of transcriptomic signatures associated with an ac4C related gene set and candidate expression based clusters in osteoarthritis through integrative bioinformatics. | PLoS One | 2026 | 42784567 | PubTator, text mining | PubMed |
| Anagrelide Remodels the PDE3A-SLFN12 Interactome to Associate with Translation Initiation Machinery in Cancer Cell Lines. | Mol Cell Proteomics | 2026 | 42759699 | PubTator, text mining | PubMed |
| The PDE3-specific inhibitor milrinone improves asthenozoospermic sperm function by regulating cAMP-PKA signaling pathway and energy metabolism. | Reprod Fertil Dev | 2026 | 42692814 | PubTator, text mining | PubMed |
| A framework to map cAMP signalling nanodomains: phosphodiesterase-centred phosphoproteome-interactome networks (pPINs) in cardiac myocytes. | J Mol Endocrinol | 2026 | 42690226 | PubTator, text mining | PubMed |
| Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion. | Tumori | 2026 | 42376758 | PubTator, text mining | PubMed |
| Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605. | Mol Cancer Ther | 2026 | 42227579 | PubTator, text mining | PubMed |
| Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A). | J Mol Med (Berl) | 2026 | 42047795 | PubTator, text mining | PubMed |
| The Role of A-Kinase Anchoring Proteins for Inhibitory cAMP Signalling in Platelets. | Cells | 2026 | 41892342 | PubTator, text mining | PubMed |
| cAMP/PKA signaling in endocrine hypertension: genetic mechanisms and pathophysiological insights. | Front Endocrinol (Lausanne) | 2026 | 41816209 | PubTator, text mining | PubMed |
| Biological implications and therapeutic potential of phosphodiesterase inhibitors: A review. | Medicine (Baltimore) | 2026 | 41790675 | PubTator, text mining | PubMed |
| Two Sides of a Coin: Molecular, metabolic, and Phenotypic Convergence in Pediatric Undernutrition and Obesity. | Curr Obes Rep | 2026 | 41770447 | PubTator, text mining | PubMed |
| Genome-wide analysis of cardiac ventricular phenotypes reveals novel loci and therapeutic targets for heart failure. | Nat Commun | 2026 | 41760662 | PubTator, text mining | PubMed |
| Targeting tRNA-Arg-TCT-4-1 suppresses cancer cell growth and tumorigenesis. | bioRxiv | 2026 | 41757043 | PubTator, text mining | PubMed |
| Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential. | Bone Rep | 2026 | 41732176 | PubTator, text mining | PubMed |
| The Role of PDE3A in Cancer. | ACS Omega | 2026 | 41726589 | PubTator, text mining | PubMed |
| AR-mediated YBX3 suppresses oocyte meiotic resumption in polycystic ovary syndrome by attenuating Pde3A and Ccnb1 expression. | J Ovarian Res | 2026 | 41673703 | PubTator, text mining | PubMed |
| Optimization of potential targets for antidepressant Chinese medicines: AI and multi-omics methods. | Chin Med | 2026 | 41668206 | PubTator, text mining | PubMed |
| Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies. | Res Sq | 2026 | 41646289 | PubTator, text mining | PubMed |
| Global RNA expression analysis of patient samples identified potential diagnostic biomarkers specific for peritoneal, ovarian and deep endometriosis. | Sci Rep | 2026 | 41526630 | PubTator, text mining | PubMed |
| Genetic predisposition and mediating pathways in ischemic stroke-induced cardiac arrhythmias: a genome-wide analysis. | J Adv Res | 2026 | 41461312 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5139/papers